Improvement in feed conversion ratio (FCR) in starter/weaner pigs treated with TPM® TPM® outperforms standard Vitamin E as feed additive in first 14 days post weaning Australian...
Claims for alleged breaches of agreements related to the development and commercialisation of Phosphagenics’ TPM® formulation of the injectable antibiotic daptomycin Australian...
Phosphagenics Provides Update on Opioid Patch Program PR Newswire MELBOURNE, Australia, July 29, 2014 MELBOURNE, Australia, July 29, 2014 /PRNewswire/ -- Next phase of the TPM®/Oxymorphone...
Phosphagenics Completes First Tranche of A$19.3 Million Capital Raising - Sold 153 million shares at A$0.08 per share - A$3 million Share Purchase Plan expected to close July 29 PR...
Phosphagenics' A$19.3 million Capital Raising - Includes A$3 million Share Purchase Plan - Upcoming opioid pain patch trials fully funded PR Newswire MELBOURNE, Australia, July 11, 2014...
Phosphagenics' Topical Oxycodone Patch Alleviates Pain in Racehorses - Rapid and effective relief for all racehorses in study - Positive implications for upcoming Phase 2 TPM(R)/Oxycodone...
Phosphagenics to Host Investor Call on Wednesday, April 2nd at 4:00pm EDT (USA) Management to Detail the Commercialization of High Value Pain Products including Oxycodone using its TPM® Topical...
Phosphagenics' Oxymorphone Patch Success PR Newswire MELBOURNE, Australia, Oct. 24, 2013 MELBOURNE, Australia, Oct. 24, 2013 /PRNewswire/ -- Oxymorphone patch achieves world first therapeutic...
Phosphagenics Signs Research Agreement with the Agricultural Research Service PR Newswire MELBOURNE, Australia, May 20, 2013 MELBOURNE, Australia, May 20, 2013 /PRNewswire/...
Phosphagenics Appoints Neura Therapeutik as US Strategic Commercial Advisors - Neura Therapeutik to advise on TPM/oxycodone program PR Newswire MELBOURNE, Australia, Aug. 1, 2012 MELBOURNE...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.